RBOT:NYE-Vicarious Surgical Inc. (USD)

COMMON STOCK | Medical Devices |

Last Closing

USD 12.99

Change

-0.24 (-1.81)%

Market Cap

USD 0.08B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-30 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
ABT Abbott Laboratories

+0.33 (+0.29%)

USD 200.50B
MDT Medtronic PLC

+0.34 (+0.43%)

USD 103.90B
ZBH Zimmer Biomet Holdings Inc

-1.17 (-1.11%)

USD 21.28B
STE STERIS plc

-3.10 (-1.51%)

USD 20.53B
GMED Globus Medical

-0.88 (-1.06%)

USD 11.25B
SNN Smith & Nephew SNATS Inc

-0.18 (-0.73%)

USD 10.75B
PEN Penumbra Inc

+2.51 (+1.06%)

USD 9.31B
BIO Bio-Rad Laboratories Inc

-2.35 (-0.72%)

USD 9.17B
BIO-B Bio-Rad Laboratories Inc

N/A

USD 9.16B
GKOS Glaukos Corp

-0.26 (-0.17%)

USD 8.32B

ETFs Containing RBOT

SLX VanEck Steel ETF 10.53 % 0.56 %

-0.34 (0.35%)

N/A
XBM:CA iShares S&P/TSX Global Ba.. 9.30 % 0.62 %

+0.10 (+0.35%)

CAD 0.24B
HAP VanEck Natural Resources .. 2.09 % 0.50 %

+0.33 (+0.35%)

USD 0.12B
FLLV 1.65 % 0.50 %

N/A

N/A
RPAR RPAR Risk Parity ETF 0.78 % 0.00 %

+0.06 (+0.35%)

USD 0.59B
SCID 0.51 % 0.39 %

N/A

N/A
JPEU 0.46 % 0.40 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.98% 69% C- 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.98% 69% C- 73% C
Trailing 12 Months  
Capital Gain 17.98% 69% C- 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.98% 69% C- 73% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 15.56% 71% C- 76% C+
Dividend Return 15.56% 71% C- 72% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 326.27% 10% F 3% F
Risk Adjusted Return 4.77% 45% F 23% F
Market Capitalization 0.08B 13% F 26% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector